FDA NDC Directory · JSON-LD · Markdown

THEOPHYLLINE

NDC 69315-226 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerLeading Pharma, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214950
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTHEOPHYLLINE (300 mg/1)
Marketing started20230515
Package count1

External sources

Source: openFDA. Public-domain (CC0).